Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 322

1.

Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.

Wallace EL, Abdel-Latif A, Charnigo R, Moliterno DJ, Brodie B, Matnani R, Ziada KM.

Am J Cardiol. 2012 Apr 1;109(7):932-40. doi: 10.1016/j.amjcard.2011.11.021. Epub 2012 Jan 3. Review.

PMID:
22221949
3.

Primary percutaneous coronary intervention for acute myocardial infarction: long-term outcome after bare metal and drug-eluting stent implantation.

Kukreja N, Onuma Y, Garcia-Garcia H, Daemen J, van Domburg R, Serruys PW.

Circ Cardiovasc Interv. 2008 Oct;1(2):103-10. doi: 10.1161/CIRCINTERVENTIONS.108.787762. Epub 2008 Sep 3.

4.

Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.

Iijima R, Byrne RA, Dibra A, Ndrepepa G, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Suttorp MJ, Violini R, Schömig A, Kastrati A.

Rev Esp Cardiol. 2009 Apr;62(4):354-64. Review. English, Spanish.

5.

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Díaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW; Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation.

Arch Intern Med. 2012 Apr 23;172(8):611-21; discussion 621-2. doi: 10.1001/archinternmed.2012.758. Review.

PMID:
22529227
6.

Comparison of outcomes for patients receiving drug-eluting versus bare metal stents for non-ST-segment elevation myocardial infarction.

Hannan EL, Samadashvili Z, Walford G, Holmes DR Jr, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, Fergus I, King SB 3rd.

Am J Cardiol. 2011 May 1;107(9):1311-8. doi: 10.1016/j.amjcard.2010.12.043.

PMID:
21497210
8.

Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected].

Philip F, Agarwal S, Bunte MC, Goel SS, Tuzcu EM, Ellis S, Kapadia SR.

Circ Cardiovasc Interv. 2014 Feb;7(1):49-61. doi: 10.1161/CIRCINTERVENTIONS.113.000412. Epub 2013 Nov 26. Erratum in: Circ Cardiovasc Interv. 2014 Feb;7(1):132. Bunte, Matthew [corrected to Bunte, Matthew C].

9.

Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).

Patel MR, Pfisterer ME, Betriu A, Widmisky P, Holmes DR Jr, O'Neill WW, Stebbins A, Van de Werf F, Armstrong PW, Granger CB; APEX-AMI Investigators.

Am J Cardiol. 2009 Jan 15;103(2):181-6. doi: 10.1016/j.amjcard.2008.08.066. Epub 2008 Nov 7.

PMID:
19121433
10.

Drug-eluting stents versus bare-metal stents in patients with decreased GFR: a meta-analysis.

Wang ZJ, Harjai KJ, Shenoy C, Gao F, Shi DM, Liu YY, Zhao YX, Zhou YJ.

Am J Kidney Dis. 2013 Oct;62(4):711-21. doi: 10.1053/j.ajkd.2013.04.014. Epub 2013 Jun 14.

PMID:
23773369
11.

Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.

Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L.

Circ Cardiovasc Interv. 2008 Dec;1(3):176-84. doi: 10.1161/CIRCINTERVENTIONS.108.794578.

12.
13.

Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.

Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Valgimigli M, Frati G, Kedhi E, Smits PC, Kaiser C, Genereux P, Galatius S, Kirtane AJ, Stone GW.

J Am Coll Cardiol. 2013 Aug 6;62(6):496-504. doi: 10.1016/j.jacc.2013.05.022. Epub 2013 Jun 7.

14.

Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.

Di Lorenzo E, Sauro R, Varricchio A, Carbone G, Cortese G, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G, De Luca G.

Circulation. 2009 Sep 15;120(11):964-72. doi: 10.1161/CIRCULATIONAHA.108.830372. Epub 2009 Aug 31. Retraction in: Circulation. 2010 Mar 2;121(8):e228.

15.

Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.

Bangalore S, Amoroso N, Fusaro M, Kumar S, Feit F.

Circ Cardiovasc Interv. 2013 Aug;6(4):378-90. doi: 10.1161/CIRCINTERVENTIONS.113.000415. Epub 2013 Aug 6. Erratum in: Circ Cardiovasc Interv. 2013 Dec;6(6):e80.

16.

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017. Review.

PMID:
19360858
17.

Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.

Boyden TF, Nallamothu BK, Moscucci M, Chan PS, Grossman PM, Tsai TT, Chetcuti SJ, Bates ER, Gurm HS.

Am J Cardiol. 2007 May 15;99(10):1399-402. Epub 2007 Apr 4.

PMID:
17493468
18.

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvänne M, Suttorp MJ, Violini R, Schömig A.

Eur Heart J. 2007 Nov;28(22):2706-13. Epub 2007 Sep 27. Review.

PMID:
17901079
19.

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.

Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Ochala A, Kellock A, Parise H, Mehran R; HORIZONS-AMI Trial Investigators.

N Engl J Med. 2009 May 7;360(19):1946-59. doi: 10.1056/NEJMoa0810116.

20.

Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.

Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW.

Circulation. 2009 Jun 30;119(25):3198-206. doi: 10.1161/CIRCULATIONAHA.108.826479. Epub 2009 Jun 15.

Supplemental Content

Support Center